In the present study, the susceptibility of the mdx mouse, a
dystrophin-deficient genetic model of
Duchenne muscular dystrophy (DMD), to various
convulsant stimuli has been evaluated and compared to three related mice strains (C57BL/6J, C57BL/10 and DBA/2 mice). Animals were treated with chemical
convulsants impairing
gamma-aminobutyric acid (
GABA) neurotransmission [
pentylenetetrazole,
picrotoxin,
bicuculline, methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (
DMCM), methyl-beta-carboline-3-carboxylate (
beta-CCM)], enhancing glutamatergic neurotransmission [
N-methyl-d-aspartate (
NMDA), alpha-amino-3-hydroxy-5-methyl-4-isoxazole
propionate (
AMPA) and
kainic acid (KA)] or a K(+) channel blocker (4-aminopyridine). Occurrence of clonic and/or
tonic seizures was evaluated to observe possible differences in seizure susceptibility. In addition, all strains of mice were repeatedly treated with a subconvulsant dose of
pentylenetetrazole (PTZ) for possible differences in kindling development. The mdx mice exhibited no difference in seizure susceptibility for all
convulsant drugs with the exception of a significantly lower sensitivity to
AMPA and KA than the other mice strains. This study demonstrates that mdx mice possess a decreased susceptibility to some
convulsant stimuli. However, mdx mice showed an enhanced seizure severity and a shorter latency in the development of chemical kindling produced by administration of PTZ. The present data suggests that the
dystrophin deficiency in mdx mice affects the pathophysiology and pharmacology of acute and chronic epileptic
seizures in an opposite manner.